
Abstract Pyruvate:ferredoxin oxidoreductases (PFORs) are key enzymes in the anaerobic metabolism of numerous diverse organisms. Their significance extends far beyond the oxidative decarboxylation of pyruvate, their canonical reaction. PFORs support diverse physiological roles, including fermentation and carbon assimilation, and have been integrated into a wide range of metabolic networks, linking carbon flux to redox balance in many bacteria and archaea, as well as in selected eukaryotes. PFORs catalyze the reversible conversion of pyruvate to acetyl‐coenzyme A coupled to the reduction of low‐potential ferredoxin. This process relies on a catalytic mechanism involving a thiamine pyrophosphate cofactor and iron–sulfur clusters. The PFOR enzymes exhibit remarkable diversity in terms of structure (subunit composition, domain architecture, and quaternary organization), function and kinetics. This diversity reflects evolutionary adaptations to different biological contexts. In this review, we examine PFOR diversity from molecular and physiological perspectives, with a focus on the enzymes that have been biochemically characterized or at least demonstrated to exhibit PFOR activity.
Abstract Accurate modeling of synthetic protein–protein interactions is essential for designing therapeutics, diagnostics, and molecular imaging reagents. Although deep learning has transformed protein structure prediction, modeling heteromeric interactions mediated by flexible loops—as in antibodies, nanobodies, and monobodies—remains challenging due to weak coevolutionary signals at binding interfaces and substantial conformational variability. Here, we present a framework that guides AlphaFold predictions of loop‐mediated interactions using synthetic multiple sequence alignments (MSAs) generated through ProteinMPNN interface design. Benchmarks across nanobody–, antibody–, and monobody–antigen complexes show that designed MSAs encode interface‐specific contact information that can be leveraged in two complementary ways. First, AlphaFold2‐Multimer and AlphaFold3 predictions conditioned on designed MSAs produce confident and accurate structures for compatible interfaces, while yielding low‐confidence or structurally inconsistent predictions for incompatible sequences or docking poses, enabling improved evaluation of candidate protein–protein complex models—particularly relevant for protein design. Second, when applied to AlphaFold‐predicted structures, designed MSAs guide structural refinement and reranking, enabling the development of a strategy that improves blind structure prediction in low‐confidence cases without exhaustive sampling. Together, these results establish designed MSAs as controllable inputs for structure prediction, with applications in protein design and blind prediction of challenging protein–protein interactions.
Modern mass spectrometry now routinely quantifies thousands of proteins and phosphosites. While raw spectral processing and quantification have matured over the past few years, downstream statistical analysis and functional interpretation remain challenging. Current tools are often fragmented across separate applications for statistics, enrichment, network analysis, and phosphoproteomics. Furthermore, they operate largely at the protein or site level, leaving the supporting peptide, precursor, and phosphosite measurements out of reach; while pathway and network visualizations are provided without subcellular context. To address these limitations, we developed ProteoAnalyst, an easy-to-use web-based platform that takes common upstream outputs (MaxQuant, FragPipe, DIA-NN, and Spectronaut) through quality control, statistical analysis, and functional interpretation within a single environment. Researchers can navigate from pathways, compartment-aware interaction networks, and kinase-substrate networks down to the individual proteins, peptides, precursors, and phosphosites that support them. Dedicated modules extend this capacity to peptide-level detection of isoform usage and post-translational modification (PTM) relative fractions, phosphoproteomics with protein abundance correction, and biomarker analysis. Our benchmarks and case studies demonstrate that ProteoAnalyst integrates well-established methods with rich functional analysis and visualization to streamline data interpretation and hypothesis generation. ProteoAnalyst is freely available at www.proteoanalyst.ca.
Abstract Tandem repeats (TRs) occur in a substantial fraction of protein sequences and exhibit distinct structural, functional, and evolutionary properties compared with aperiodic regions that form globular folds. Although TRs often originate as highly periodic sequences, they can progressively diverge through mutation while retaining residual periodicity, complicating their reliable detection. Numerous computational tools have been developed for TR identification, but benchmarking studies show that no single method performs optimally across all repeat classes, as performance varies depending on repeat type and length. To address these limitations, we developed Meta Repeat Finder, a comprehensive framework that integrates multiple TR detection methods, each optimized for specific repeat length ranges, into a unified pipeline. Meta Repeat Finder applies stringent validation criteria to the combined outputs of multiple detectors to identify structurally and functionally relevant TR regions. The pipeline supports standardized integration of new TR detection tools under defined criteria, ensuring consistent scoring, terminal repeat trimming followed by TR re‐assessment, and generation of a non‐redundant TR set. Results are presented through a web interface at https://bioinfo.crbm.cnrs.fr/mrf offering graphical visualization and downloadable tabular data. A command‐line implementation is also available for large‐scale analyses.
Abstract Urease, a binuclear nickel metalloenzyme central to microbial survival and pathogenicity, is a key protein target for mechanism‐guided inhibitor design. In this study, nine morpholine‐containing 1,2,4‐triazole‐based N ‐Mannich derivatives ( mb1–9 ) were synthesized through sequential Schiff‐base formation and Mannich functionalization and structurally characterized by FT‐IR, 1 H/ 13 C‐NMR, and HRMS analyses. In vitro urease‐inhibition assays revealed marked structure‐dependent activity, with mb4 exhibiting the highest potency (IC 50 = 5.55 μM), followed by mb7 (12.92 μM), both outperforming the reference inhibitor thiourea (IC 50 = 20.84 μM). The experimental activity profile was rationalized by molecular docking and molecular dynamics simulations, which demonstrated that productive inhibition is associated with persistent accommodation of the ligands within the catalytic pocket, coordination of the morpholine oxygen toward the binuclear Ni center, and additional stabilization involving the triazole carbonyl and Cys321. Although the calculated docking scores were relatively close across the series, mb4 adopted a particularly favorable binding geometry that simultaneously preserved metal‐centered interactions and active‐site stabilization, providing a structural basis for its superior experimental potency. Consistently, MD simulations showed that the more active aromatic derivatives, particularly mb4 , mb5 , and mb7 , maintained comparatively stable binding conformations with limited structural fluctuations, whereas less active and more conformationally flexible analogs exhibited greater mobility within the active‐site environment. MM/GBSA analysis further supported favorable binding of mb4 , while diffusion‐map analysis identified a dominant, well‐defined low‐energy conformational basin, indicating persistent ligand retention under dynamic conditions. Membrane‐permeation simulations and ADME predictions additionally suggested physiologically compatible passive diffusion and favorable drug‐like properties. The convergence of experimental inhibition data with metal coordination, active‐site interaction patterns, and dynamic stability identifies mb4 as the most promising mechanistically supported urease‐inhibitory scaffold within the series.